1-20 of 603 Search Results for

values

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Published: 09 March 2018
DOI: 10.1215/9780822372066-017
EISBN: 978-0-8223-7206-6
Published: 15 July 2016
DOI: 10.1215/9780822374237
EISBN: 978-0-8223-7423-7
Published: 01 January 2016
DOI: 10.1215/9780822374596
EISBN: 978-0-8223-7459-6
Published: 21 August 2015
DOI: 10.1215/9780822375548
EISBN: 978-0-8223-7554-8
Published: 01 January 1998
DOI: 10.1215/9780822397922-025
EISBN: 978-0-8223-9792-2
Series: e-Duke books scholarly collection.
Published: 30 January 2009
DOI: 10.1215/9780822392439-004
EISBN: 978-0-8223-9243-9
Series: Series Q
Published: 28 June 2006
DOI: 10.1215/9780822387985-003
EISBN: 978-0-8223-8798-5
Series: e-Duke books scholarly collection.
Published: 23 March 2009
DOI: 10.1215/9780822390800
EISBN: 978-0-8223-9080-0
Series: Experimental Futures
Published: 10 February 2017
DOI: 10.1215/9780822373285-007
EISBN: 978-0-8223-7328-5
Series: Experimental Futures
Published: 10 February 2017
DOI: 10.1215/9780822373285-008
EISBN: 978-0-8223-7328-5
... generated enormous controversy and became a fulcrum around which a broader politics concerned with clinical trials in India emerged. This raises questions not just about relationships between health, value, and politics, but also of the configuration of epidemiological knowledge and technocratic forms...
Series: Experimental Futures
Published: 10 February 2017
DOI: 10.1215/9780822373285-009
EISBN: 978-0-8223-7328-5
... the legal history of an anticancer drug, Gleevec, in India between 2005 and 2013 to consider the place of the law and judicial governance in articulations of health, value, knowledge, and politics. access to medicines chronic myeloid leukemia (CML) constitutionalism evergreening Gleevec...
Series: Experimental Futures
Published: 10 February 2017
DOI: 10.1215/9780822373285-010
EISBN: 978-0-8223-7328-5
... This chapter describes the incorporation of ethical and normative commitments into the value-generating activities of the multinational R&D-driven pharmaceutical industry through discourses of innovation and materialized through practices of corporate social responsibility. I focus...
Series: Experimental Futures
Published: 10 February 2017
DOI: 10.1215/9780822373285-011
EISBN: 978-0-8223-7328-5
... This chapter describes the incorporation of ethical and normative commitments into the value-generating activities of the multinational R&D-driven pharmaceutical industry through discourses of innovation and materialized through practices of corporate social responsibility. I focus...
Published: 01 September 2017
DOI: 10.1215/9780822372448-007
EISBN: 978-0-8223-7244-8
Series: [sic] Series
Published: 30 April 2003
DOI: 10.1215/9780822384724-005
EISBN: 978-0-8223-8472-4
Published: 09 November 2010
DOI: 10.1215/9780822393221-006
EISBN: 978-0-8223-9322-1
Published: 01 January 2006
DOI: 10.1215/9780822387763-006
EISBN: 978-0-8223-8776-3
Series: Latin America Otherwise
Published: 18 May 2005
DOI: 10.1215/9780822386612-003
EISBN: 978-0-8223-8661-2
Series: Politics, History, and Culture
Published: 25 April 2005
DOI: 10.1215/9780822386889-016
EISBN: 978-0-8223-8688-9
Published: 28 March 2003
DOI: 10.1215/9780822384526-007
EISBN: 978-0-8223-8452-6